Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.274
Filter
1.
Sci Rep ; 14(1): 15631, 2024 Jul 07.
Article in English | MEDLINE | ID: mdl-38972872

ABSTRACT

The use of lactose and cow milk protein (CMP) as potential allergens in pharmaceuticals and their ability to cause allergic reactions remains a significant concern in medicine. Lactose, a common pharmaceutical excipient due to its inert, inexpensive, and stable properties, is found in many prescription-only and over-the-counter medications. However, despite their widespread use, individuals with lactose intolerance (LI) or cow milk protein allergy (CMPA) may experience adverse reactions to these excipients. This study investigated the prevalence of lactose and other dairy-derived ingredients in pharmaceuticals marketed in Portugal. Using the Summary of Product Characteristics (SmPC) from the INFOMED database, various medications, including analgesics, antipyretics, non-steroidal anti-inflammatory drugs (NSAIDs), and antiasthmatics, were analyzed. Results showed a high prevalence of dairy-derived excipients, particularly in antiasthmatic drugs (62.6%) and NSAIDs (39%). Although CMP are not explicitly mentioned in SmPCs, the presence of lactose as an ingredient poses a risk of cross-contamination. The findings emphasize the need for healthcare professionals to be aware of potential allergens in medications and the importance of developing lactose-free alternatives to ensure the safety of patients with LI and CMPA. Further research is required to assess the safety and implications of lactose in medicines for these populations.


Subject(s)
Excipients , Lactose Intolerance , Lactose , Milk Hypersensitivity , Humans , Excipients/adverse effects , Excipients/chemistry , Milk Hypersensitivity/epidemiology , Animals , Lactose/adverse effects , Lactose/analysis , Lactose/chemistry , Cattle , Milk Proteins/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/analysis , Allergens/analysis , Portugal , Dairy Products/analysis , Dairy Products/adverse effects
2.
Biomacromolecules ; 25(7): 4428-4439, 2024 Jul 08.
Article in English | MEDLINE | ID: mdl-38917058

ABSTRACT

Carbonyl cross-linkers are used to modify textiles and form resins, and are produced annually in megatonne volumes. Due to their toxicity toward the environment and human health, however, less harmful biobased alternatives are needed. This study introduces carbonyl groups to lactose and galactose using galactose oxidase from Fusarium graminearum (FgrGalOx) and pyranose dehydrogenase from Agaricus bisporus (AbPDH1) to produce four cross-linkers. Differential scanning calorimetry was used to compare cross-linker reactivity, most notably resulting in a 34 °C decrease in reaction peak temperature (72 °C) for FgrGalOx-oxidized galactose compared to unmodified galactose. Attenuated total reflectance Fourier-transform infrared (ATR-FTIR) spectroscopy, X-ray photoelectron spectroscopy (XPS), and proton nuclear magnetic resonance (1H NMR) spectroscopy were used to verify imine formation and amine and aldehyde depletion. Cross-linkers were shown to form gels when mixed with polyallylamine, with FgrGalOx-oxidized lactose forming gels more effectively than all other cross-linkers, including glutaraldehyde. Further development of carbohydrate cross-linker technologies could lead to their adoption in various applications, including in adhesives, resins, and textiles.


Subject(s)
Cross-Linking Reagents , Oxidation-Reduction , Polyamines , Cross-Linking Reagents/chemistry , Polyamines/chemistry , Galactose Oxidase/chemistry , Galactose Oxidase/metabolism , Galactose/chemistry , Lactose/chemistry , Agaricus/chemistry , Carbohydrates/chemistry
3.
Int J Biol Macromol ; 273(Pt 1): 132992, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38857718

ABSTRACT

ß-D-galactosidase is a hydrolase enzyme capable of hydrolyzing lactose in milk-based foods. Its free form can be inactivated in solution during the production of low-dosage lactose foods. Then, it is important to study strategies for avoiding the free enzyme inactivation with the aim of circumventing this problem. The stabilization of ß-D-galactosidase in aqueous solution after interactions with chitosan/eucalyptus sawdust composite membrane proved to be a potential strategy when optimized by central composite rotatable (CCR) design. In this case, the best experimental conditions for ß-D-galactosidase partitioning and stability in an aqueous medium containing the chitosan-based composite membrane reinforced with eucalyptus sawdust were i) enzyme/buffer solution ratio of 0.0057, ii) pH 5.6, iii) membrane mass of 50 mg, and iv) temperature lower than 37 °C. Significance was found for the linear enzyme/buffer solution ratio, linear temperature, and quadratic pH (p < 0.05) in the interval between 0 and 60 min of study. In the interval between 60 and 120 min, there was significance (p < 0.12) for linear temperature, the temperature-enzyme/buffer solution ratio interaction and the interaction between linear pH and linear enzyme/buffer solution ratio. The Pareto charts and response surfaces clearly showed all the effects of the experimental variables on the stabilization of ß-D-galactosidase in solution after interactions with the chitosan composite membrane. In this case, industrial food reactors covered with chitosan/eucalyptus sawdust composite membrane could be a strategy for the hydrolysis of lactose during milk-producing processes.


Subject(s)
Chitosan , Enzyme Stability , beta-Galactosidase , Chitosan/chemistry , beta-Galactosidase/chemistry , beta-Galactosidase/metabolism , Hydrogen-Ion Concentration , Membranes, Artificial , Solutions , Temperature , Lactose/chemistry
4.
Pharm Res ; 41(6): 1201-1216, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38834905

ABSTRACT

BACKGROUND: Some glucoside drugs can be transported via intestinal glucose transporters (IGTs), and the presence of carbohydrate excipients in pharmaceutical formulations may influence the absorption of them. This study, using gastrodin as probe drug, aimed to explore the effects of fructose, lactose, and arabic gum on intestinal drug absorption mediated by the glucose transport pathway. METHODS: The influence of fructose, lactose, and arabic gum on gastrodin absorption was assessed via pharmacokinetic experiments and single-pass intestinal perfusion. The expression of sodium-dependent glucose transporter 1 (SGLT1) and sodium-independent glucose transporter 2 (GLUT2) was quantified via RT‒qPCR and western blotting. Alterations in rat intestinal permeability were evaluated through H&E staining, RT‒qPCR, and immunohistochemistry. RESULTS: Fructose reduced the area under the curve (AUC) and peak concentration (Cmax) of gastrodin by 42.7% and 63.71%, respectively (P < 0.05), and decreased the effective permeability coefficient (Peff) in the duodenum and jejunum by 58.1% and 49.2%, respectively (P < 0.05). SGLT1 and GLUT2 expression and intestinal permeability remained unchanged. Lactose enhanced the AUC and Cmax of gastrodin by 31.5% and 65.8%, respectively (P < 0.05), and increased the Peff in the duodenum and jejunum by 33.7% and 26.1%, respectively (P < 0.05). SGLT1 and GLUT2 levels did not significantly differ, intestinal permeability increased. Arabic gum had no notable effect on pharmacokinetic parameters, SGLT1 or GLUT2 expression, or intestinal permeability. CONCLUSION: Fructose, lactose, and arabic gum differentially affect intestinal drug absorption through the glucose transport pathway. Fructose competitively inhibited drug absorption, while lactose may enhance absorption by increasing intestinal permeability. Arabic gum had no significant influence.


Subject(s)
Benzyl Alcohols , Excipients , Fructose , Glucose Transporter Type 2 , Glucose , Glucosides , Gum Arabic , Intestinal Absorption , Lactose , Rats, Sprague-Dawley , Sodium-Glucose Transporter 1 , Animals , Intestinal Absorption/drug effects , Glucosides/pharmacology , Glucosides/administration & dosage , Glucosides/pharmacokinetics , Sodium-Glucose Transporter 1/metabolism , Sodium-Glucose Transporter 1/genetics , Male , Glucose Transporter Type 2/metabolism , Glucose Transporter Type 2/genetics , Rats , Excipients/chemistry , Excipients/pharmacology , Glucose/metabolism , Lactose/chemistry , Benzyl Alcohols/pharmacology , Benzyl Alcohols/pharmacokinetics , Intestinal Mucosa/metabolism , Intestinal Mucosa/drug effects , Biological Transport/drug effects , Permeability/drug effects
5.
AAPS PharmSciTech ; 25(6): 138, 2024 Jun 18.
Article in English | MEDLINE | ID: mdl-38890193

ABSTRACT

Unexpected cross-contamination by foreign components during the manufacturing and quality control of pharmaceutical products poses a serious threat to the stable supply of drugs and the safety of customers. In Japan, in 2020, a mix-up containing a sleeping drug went undetected by liquid chromatography during the final quality test because the test focused only on the main active pharmaceutical ingredient (API) and known impurities. In this study, we assessed the ability of a powder rheometer to analyze powder characteristics in detail to determine whether it can detect the influence of foreign APIs on powder flow. Aspirin, which was used as the host API, was combined with the guest APIs (acetaminophen from two manufacturers and albumin tannate) and subsequently subjected to shear and stability tests. The influence of known lubricants (magnesium stearate and leucine) on powder flow was also evaluated for standardized comparison. Using microscopic morphological analysis, the surface of the powder was observed to confirm physical interactions between the host and guest APIs. In most cases, the guest APIs were statistically detected due to characteristics such as their powder diameter, pre-milling, and cohesion properties. Furthermore, we evaluated the flowability of a formulation incorporating guest APIs for direct compression method along with additives such as microcrystalline cellulose, potato starch, and lactose. Even in the presence of several additives, the influence of the added guest APIs was successfully detected. In conclusion, powder rheometry is a promising method for ensuring stable product quality and reducing the risk of unforeseen cross-contamination by foreign APIs.


Subject(s)
Drug Contamination , Powders , Rheology , Powders/chemistry , Rheology/methods , Drug Contamination/prevention & control , Excipients/chemistry , Acetaminophen/chemistry , Cellulose/chemistry , Pharmaceutical Preparations/chemistry , Quality Control , Aspirin/chemistry , Chemistry, Pharmaceutical/methods , Lactose/chemistry , Drug Compounding/methods , Lubricants/chemistry , Bulk Drugs
6.
AAPS PharmSciTech ; 25(6): 147, 2024 Jun 27.
Article in English | MEDLINE | ID: mdl-38937406

ABSTRACT

Only few excipients are known to be suitable as pelletization aids. In this study, the potential use of croscarmellose sodium (CCS) as pelletization aid was investigated. Furthermore, the impact of cations on extrusion-spheronization (ES) of CCS was studied and different grades of CCS were tested. The influence of different cations on the swelling of CCS was investigated by laser diffraction. Mixtures of CCS with lactose monohydrate as filler with or without the inclusion of different cations were produced. The mixtures were investigated by mixer torque rheometry and consequently extruded and spheronized. Resulting pellets were analyzed by dynamic image analysis. In addition, mixtures of different CCS grades with dibasic calcium phosphate anhydrous (DP) and a mixture with praziquantel (PZQ) as filler were investigated. Calcium and magnesium cations caused a decrease of the swelling of CCS and influenced the use of CCS as pelletization aid since they needed to be included for successful ES. Aluminum, however, led to an aggregation of the CCS particles and to failure of extrusion. The inclusion of cations decreased the uptake of water by the mixtures which also reduced the liquid-to-solid-ratio (L/S) for successful ES. This was shown to be dependent on the amount of divalent cations in the mixture. With DP or PZQ as filler, no addition of cations was necessary for a successful production of pellets, however the optimal L/S for ES was dependent on the CCS grade used. In conclusion, CCS can be used as a pelletization aid.


Subject(s)
Excipients , Particle Size , Excipients/chemistry , Drug Compounding/methods , Calcium Phosphates/chemistry , Lactose/chemistry , Chemistry, Pharmaceutical/methods , Cations/chemistry , Praziquantel/chemistry , Magnesium/chemistry
7.
Int J Pharm ; 659: 124290, 2024 Jun 25.
Article in English | MEDLINE | ID: mdl-38821435

ABSTRACT

The influence of hydroxypropyl cellulose type (HPC-SSL SFP, HPC-SSL), concentration (2 %, 3.5 %, 5 %) and filler (lactose, calcium hydrogen phosphate (DCP)/microcrystalline cellulose (MCC)) on twin-screw wet granulation and subsequent tableting was studied. The aim was to identify the formulation of the highest tabletability which still fulfills the requirements of the disintegration. Lactose combined with 5 % binder enabled a higher tabletability and a faster disintegration than DCP/MCC. It was found that tabletability of lactose formulations can be increased by higher binder concentration and higher compression pressure while tabletability of DCP/MCC formulations can be only increased by higher compression pressure. It was observed that batches containing DCP/MCC failed the disintegration test, if the highest binder concentration and the highest compression pressure were used. To ensure a fast disintegration, the compression pressure or at least the binder concentration had to be low. Changing the disintegrant and its localization improved the DCP/MCC formulation, resulting in faster disintegration than lactose tablets. However, it also resulted in a lower tabletability. In this study best tablets were achieved with 3.5 % or 5 % binder and lactose as filler. These tablets presented the highest tabletability but still disintegrated in less than 500 s.


Subject(s)
Cellulose , Drug Compounding , Excipients , Lactose , Tablets , Cellulose/chemistry , Cellulose/analogs & derivatives , Lactose/chemistry , Excipients/chemistry , Drug Compounding/methods , Calcium Phosphates/chemistry , Chemistry, Pharmaceutical/methods , Pressure , Solubility
8.
Food Res Int ; 183: 114175, 2024 May.
Article in English | MEDLINE | ID: mdl-38760120

ABSTRACT

Lactose hydrolysed concentrated milk was prepared using ß-galactosidase enzyme (4.76U/mL) with a reaction period of 12 h at 4 °C. Addition of polysaccharides (5 % maltodextrin/ß-cyclodextrin) to concentrated milk either before or after lactose hydrolysis did not result in significant differences (p > 0.05) in degree of hydrolysis (% DH) of lactose and residual lactose content (%). Three different inlet temperatures (165 °C, 175 °C and 185 °C) were used for the preparation of powders which were later characterised based on physico-chemical and maillard browning characteristics. Moisture content, solubility and available lysine content of the powders decreased significantly, whereas, browning parameters i.e., browning index, 5-hydroxymethylfurfural, furosine content increased significantly (p < 0.05) with an increase in inlet air temperature. The powder was finally prepared with 5 % polysaccharide and an inlet air temperature of 185 °C which reduced maillard browning. Protein-polysaccharide interactions were identified using Fourier Transform infrared spectroscopy, fluorescence spectroscopy and determination of free amino groups in the powder samples. Maltodextrin and ß-cyclodextrin containing powder samples exhibited lower free amino groups and higher degree of graft value as compared to control sample which indicated protein-polysaccharide interactions. Results obtained from Fourier Transform infrared spectroscopy also confirmed strong protein-polysaccharide interactions, moreover a significant decrease in fluorescence intensity was also observed in the powder samples. These interactions between the proteins and polysaccharides reduced the maillard browning in powders.


Subject(s)
Furaldehyde , Lactose , Maillard Reaction , Milk , Polysaccharides , Powders , Lactose/chemistry , Polysaccharides/chemistry , Milk/chemistry , Animals , Spectroscopy, Fourier Transform Infrared , Furaldehyde/analogs & derivatives , Furaldehyde/chemistry , beta-Galactosidase/metabolism , beta-Cyclodextrins/chemistry , Hydrolysis , Spray Drying , Temperature , Lysine/chemistry , Lysine/analogs & derivatives , Solubility , Spectrometry, Fluorescence , Milk Proteins/chemistry , Food Handling/methods
9.
Int J Pharm ; 657: 124190, 2024 May 25.
Article in English | MEDLINE | ID: mdl-38701910

ABSTRACT

Lubricants are essential for most tablet formulations as they assist powder flow, prevent adhesion to tableting tools and facilitate tablet ejection. Magnesium stearate (MgSt) is an effective lubricant but may compromise tablet strength and disintegratability. In the design of orodispersible tablets, tablet strength and disintegratability are critical attributes of the dosage form. Hence, this study aimed to conduct an in-depth comparative study of MgSt with alternative lubricants, namely sodium lauryl sulphate (SLS), stearic acid (SA) and hydrogenated castor oil (HCO), for their effects on the tableting process as well as tablet properties. Powder blends were prepared with lactose, sodium starch glycolate or crospovidone as the disintegrant, and a lubricant at different concentrations. Angle of repose was determined for the mixtures. Comparative evaluation was carried out based on the ejection force, tensile strength, liquid penetration and disintegratability of the tablets produced. As the lubricant concentration increased, powder flow and tablet ejection improved. The lubrication efficiency generally decreased as follows: MgSt > HCO > SA > SLS. Despite its superior lubrication efficacy, MgSt is the only lubricant of four evaluated that reduced tablet tensile strength. Tablet disintegration time was strongly determined by tensile strength and liquid penetration, which were in turn affected by the lubricant type and concentration. All the above factors should be taken into consideration when deciding the type and concentration of lubricant for an orodispersible tablet formulation.


Subject(s)
Excipients , Lubricants , Stearic Acids , Tablets , Tensile Strength , Lubricants/chemistry , Stearic Acids/chemistry , Excipients/chemistry , Drug Compounding/methods , Powders/chemistry , Sodium Dodecyl Sulfate/chemistry , Castor Oil/chemistry , Povidone/chemistry , Starch/chemistry , Starch/analogs & derivatives , Lactose/chemistry , Administration, Oral , Solubility , Chemistry, Pharmaceutical/methods
10.
Bioprocess Biosyst Eng ; 47(6): 919-929, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38644439

ABSTRACT

The growing need in the current market for innovative solutions to obtain lactose-free (L-F) milk is caused by the annual increase in the prevalence of lactose intolerance inside as well as the newborn, children, and adults. Various configurations of enzymes can yield two distinct L-F products: sweet (ß-galactosidase) and unsweet (ß-galactosidase and glucose oxidase) L-F milk. In addition, the reduction of sweetness through glucose decomposition should be performed in a one-pot mode with catalase to eliminate product inhibition caused by H2O2. Both L-F products enjoy popularity among a rapidly expanding group of consumers. Although enzyme immobilization techniques are well known in industrial processes, new carriers and economic strategies are still being searched. Polymeric carriers, due to the variety of functional groups and non-toxicity, are attractive propositions for individual and co-immobilization of food enzymes. In the presented work, two strategies (with free and immobilized enzymes; ß-galactosidase NOLA, glucose oxidase from Aspergillus niger, and catalase from Serratia sp.) for obtaining sweet and unsweet L-F milk under low-temperature conditions were proposed. For free enzymes, achieving the critical assumption, lactose hydrolysis and glucose decomposition occurred after 1 and 4.3 h, respectively. The tested catalytic membranes were created on regenerated cellulose and polyamide. In both cases, the time required for lactose and glucose bioconversion was extended compared to free enzymes. However, these preparations could be reused for up to five (ß-galactosidase) and ten cycles (glucose oxidase with catalase).


Subject(s)
Enzymes, Immobilized , Glucose Oxidase , Lactose , Milk , beta-Galactosidase , beta-Galactosidase/metabolism , beta-Galactosidase/chemistry , Milk/chemistry , Lactose/metabolism , Lactose/chemistry , Glucose Oxidase/chemistry , Glucose Oxidase/metabolism , Enzymes, Immobilized/chemistry , Enzymes, Immobilized/metabolism , Animals , Aspergillus niger/enzymology , Glucose/metabolism , Glucose/chemistry , Catalase/metabolism , Catalase/chemistry , Membranes, Artificial
11.
Int J Pharm ; 656: 124116, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38615803

ABSTRACT

Inhalation of pharmaceutical aerosol formulations is widely used to treat respiratory diseases. Spatially resolved thermal characterization offers promise for better understanding drug release rates from particles; however, this has been an analytical challenge due to the small particle size (from a few micrometers down to nanometers) and the complex composition of the formulations. Here, we employ nano-thermal analysis (nanoTA) to probe the nanothermal domain of a pharmaceutical aerosol formulation containing a mixture of fluticasone propionate (FP), salmeterol xinafoate (SX), and excipient lactose, which is widely used to treat asthma and chronic obstructive pulmonary disease (COPD). Furthermore, atomic force microscopy-infrared spectroscopy (AFM-IR) and AFM force measurements are performed to provide nanochemical and nanomechanical information to complement the nanothermal data. The colocalized thermal and chemical mapping clearly reveals the surface heterogeneity of the drugs in the aerosol particles and demonstrates the contribution of the surface chemical composition to the variation in the thermal properties of the particles. We present a powerful analytical approach for in-depth characterization of thermal/chemical/morphological properties of dry powder inhaler particles at micro- and nanometer scales. This approach can be used to facilitate the comparison between generics and reference inhalation products and further the development of high-performance pharmaceutical formulations.


Subject(s)
Aerosols , Dry Powder Inhalers , Fluticasone , Lactose , Microscopy, Atomic Force , Particle Size , Powders , Salmeterol Xinafoate , Fluticasone/chemistry , Fluticasone/administration & dosage , Salmeterol Xinafoate/chemistry , Salmeterol Xinafoate/administration & dosage , Lactose/chemistry , Microscopy, Atomic Force/methods , Excipients/chemistry , Administration, Inhalation , Bronchodilator Agents/administration & dosage , Bronchodilator Agents/chemistry , Spectrophotometry, Infrared/methods , Chemistry, Pharmaceutical/methods , Surface Properties
12.
Int J Pharm ; 658: 124150, 2024 Jun 10.
Article in English | MEDLINE | ID: mdl-38663645

ABSTRACT

This study investigates decompression and ejection conditions on tablet characteristics by comparing compact densities and tensile strengths made using regular rigid dies and custom-built die systems that enable triaxial decompression. Die-wall pressure evolution during decompression and ejection stresses did not meaningfully impact the density and tensile strength of the materials tested: microcrystalline cellulose, crystalline lactose monohydrate, and mannitol. Furthermore, the apparent differences in tensile strength between rectangular cuboids and cylindrical compacts are unrelated to decompression and ejection conditions, but rather a consequence of their shapes and of the test configurations. This suggests that elastic and plastic deformations that may occur during decompression and ejection are not significantly influenced by die-wall pressure evolution. We thus conclude that while triaxial decompression and constraint-free ejection may allow the production of defect-free compacts for materials that otherwise are defect prone using a rigid die, they seem to pose no benefits when the materials already produce defect-free compacts using a rigid die.


Subject(s)
Cellulose , Excipients , Lactose , Mannitol , Tablets , Tensile Strength , Cellulose/chemistry , Lactose/chemistry , Mannitol/chemistry , Excipients/chemistry , Technology, Pharmaceutical/methods , Pressure , Drug Compounding/methods , Chemistry, Pharmaceutical/methods
13.
Biomater Adv ; 160: 213849, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38599041

ABSTRACT

Spheroids derived from human mesenchymal stem cells (hMSCs) are of limited use for cartilage regeneration, as the viability of the cells progressively decreases during the period required for chondrogenic differentiation (21 days). In this work, spheroids based on hMSCs and a lactose-modified chitosan (CTL) were formed by seeding cells onto an air-dried coating of CTL. The polymer coating can inhibit cell adhesion and it is simultaneously incorporated into spheroid structure. CTL-spheroids were characterized from a morphological and biological perspective, and their properties were compared with those of spheroids obtained by seeding the cells onto a non-adherent surface (agar gel). Compared to the latter, smaller and more viable spheroids form in the presence of CTL as early as 4 days of culture. At this time point, analysis of stem cells differentiation in spheroids showed a remarkable increase in collagen type-2 (COL2A1) gene expression (~700-fold compared to day 0), whereas only a 2-fold increase was observed in the control spheroids at day 21. These results were confirmed by histological and transmission electron microscopy (TEM) analyses, which showed that in CTL-spheroids an early deposition of collagen with a banding structure already occurred at day 7. Overall, these results support the use of CTL-spheroids as a novel system for cartilage regeneration, characterized by increased cell viability and differentiation capacity within a short time-frame. This will pave the way for approaches aimed at increasing the success rate of procedures and reducing the time required for tissue regeneration.


Subject(s)
Cell Differentiation , Chitosan , Chondrogenesis , Lactose , Mesenchymal Stem Cells , Spheroids, Cellular , Chitosan/pharmacology , Chitosan/chemistry , Mesenchymal Stem Cells/drug effects , Mesenchymal Stem Cells/cytology , Humans , Cell Differentiation/drug effects , Chondrogenesis/drug effects , Spheroids, Cellular/drug effects , Spheroids, Cellular/cytology , Lactose/pharmacology , Lactose/chemistry , Cell Survival/drug effects , Cells, Cultured , Collagen Type II/metabolism , Collagen Type II/genetics
14.
Int J Pharm ; 657: 124122, 2024 May 25.
Article in English | MEDLINE | ID: mdl-38621619

ABSTRACT

The aim of this study was to investigate how the propensity for aerosolisation in binary adhesive mixtures was affected by the drug load, and to determine whether these findings could be linked to different blend states. Binary blends of two different lactose carriers, each with varying size and morphology, were prepared together with budesonide. In vitro aerosolisation studies were conducted at four different pressure drops, ranging from 0.5 to 4 kPa, utilising a Next Generation Impactor. Several dispersion parameters were derived from the relationship between the quantity of dispersed API and the pressure drop. The evolution of the parameters with drug load was complex, especially at low drug loads. While similar responses were observed for both carriers, the range of drug load that could be used varied significantly. The choice of carrier not only influenced the capacity for drug loading but also affected the spatial distribution of the API within the mixture, which, in turn, affected its aerosolisation propensity. Thus, the drug dispersion process could be linked to different configurations of the lactose carrier and budesonide in the blends, i.e. blend states. In conclusion, the study suggests that the concept of blend states can provide an explanation for the complex dispersion process observed in adhesive blends.


Subject(s)
Adhesives , Aerosols , Budesonide , Drug Carriers , Lactose , Budesonide/chemistry , Budesonide/administration & dosage , Lactose/chemistry , Administration, Inhalation , Adhesives/chemistry , Drug Carriers/chemistry , Particle Size , Chemistry, Pharmaceutical/methods
15.
Int J Pharm ; 656: 124059, 2024 May 10.
Article in English | MEDLINE | ID: mdl-38552753

ABSTRACT

Most of biopharmaceuticals, in their liquid form, are prone to instabilities during storage. In order to improve their stability, lyophilization is the most commonly used drying technique in the pharmaceutical industry. In addition, certain applications of biopharmaceutical products can be considered by oral administration and tablets are the most frequent solid pharmaceutical dosage form used for oral route. Thus, the tableting properties of freeze-dried products used as cryo and lyoprotectant could be a key element for future pharmaceutical developments and applications. In this study, we investigated the properties that might play a particular role in the specific compaction behavior of freeze-dried excipients. The tableting properties of freeze-dried trehalose, lactose and mannitol were investigated and compared to other forms of these excipients (spray-dried, commercial crystalline and commercial crystalline milled powders). The obtained results showed a specific behavior in terms of compressibility, tabletability and brittleness for the amorphous powders obtained after freeze-drying. The comparison with the other powders showed that this specific tableting behavior is linked to both the specific texture and the physical state (amorphization) of these freeze-dried powders.


Subject(s)
Drug Compounding , Excipients , Freeze Drying , Lactose , Mannitol , Powders , Tablets , Trehalose , Excipients/chemistry , Mannitol/chemistry , Drug Compounding/methods , Trehalose/chemistry , Lactose/chemistry , Powders/chemistry , Spray Drying , Chemistry, Pharmaceutical/methods
16.
Int J Pharm ; 655: 123966, 2024 Apr 25.
Article in English | MEDLINE | ID: mdl-38452834

ABSTRACT

The potential of fine excipient materials to improve the aerodynamic performance of carrier-based dry powder inhalation (DPI) formulations is well acknowledged but not fully elucidated. To improve the understanding of this potential, we studied two fine excipient materials: micronized lactose particles and silica microspheres. Inhalation formulations, each composed of a coarse lactose carrier, one of the two fine excipient materials (0.0-15.0 % w/w), and a spray-dried drug (fluticasone propionate) material (1.5 % w/w) were prepared. The physical structure, the flow behavior, the aerosolization behavior, and the aerodynamic performance of the formulations were studied. The two fine excipient materials similarly occupied carrier surface macropores. However, only the micronized lactose particles formed agglomerates and appeared to increase the tensile strength of the formulations. At 2.5 % w/w, the two fine excipient materials similarly improved drug dispersibility, whereas at higher concentrations, the micronized lactose material was more beneficial than the silica microspheres. The findings suggest that fine excipient materials improve drug dispersibility from carrier-based DPI formulations at low concentrations by filling carrier surface macropores and at high concentrations by forming agglomerates and/or enforcing fluidization. The study emphasizes critical attributes of fine excipient materials in carrier-based DPI formulations.


Subject(s)
Excipients , Lactose , Excipients/chemistry , Powders/chemistry , Lactose/chemistry , Drug Carriers/chemistry , Dry Powder Inhalers , Administration, Inhalation , Surface Properties , Silicon Dioxide , Particle Size , Aerosols/chemistry
17.
Int J Pharm ; 654: 123924, 2024 Apr 10.
Article in English | MEDLINE | ID: mdl-38395318

ABSTRACT

Amorphous solid dispersion (ASD) is an effective approach for enhancing the solubility, dissolution, and bioavailability of poorly water-soluble drugs. However, these metastable forms can transform into more thermodynamically stable but less soluble crystalline forms. Despite this challenge, research on processing ASDs into solid dosage forms, such as tablets, is lacking. This work aims to fill this gap by investigating the impact of common diluents on the tableting behavior, dissolution, and physical stability of ASDs composed of itraconazole and hypromellose acetate succinate. Four widely used diluents found in commercially available ASD tablets were selected for the study: microcrystalline cellulose (MCC), anhydrous lactose, starch, and mannitol. The performance of ASD tablets varied significantly depending on the diluent used. Tablets prepared with MCC exhibited higher mechanical strength than those formulated using other diluents. ASD tablets containing mannitol and lactose revealed a faster release rate than those composed of MCC or starch. Notably, the study highlighted that the physical stability of ASDs within a tablet is not solely dependent on the amount of sorbed water; crystalline diluents like lactose and mannitol were found to facilitate ASD recrystallization within a tablet. In summary, the study underscores the importance of excipient selection, considering factors such as mechanical strength, dissolution rate, and physical stability of ASD tablets. These findings offer valuable insights into the selection of excipients for downstream ASD tablet development, leading to improved manufacturability, physical stability, and the overall quality of ASD drug products.


Subject(s)
Chemistry, Pharmaceutical , Excipients , Excipients/chemistry , Lactose/chemistry , Solubility , Starch , Tablets/chemistry , Mannitol , Water , Drug Compounding
18.
Org Biomol Chem ; 22(10): 2091-2097, 2024 03 06.
Article in English | MEDLINE | ID: mdl-38363206

ABSTRACT

Galactooligosaccharides (GOS) are widely used as a supplement in infant nutrition to mimic the beneficial effects found in prebiotic human milk oligosaccharides (HMOs). However, the complexity of the GOS mixture makes it challenging to ascertain which of the GOS components contribute most to their health benefits. Galactosyllactoses (GLs) are lactose-based trisaccharides containing a ß-galactopyranosyl residue at the 3'-position (3'galactosyllactose, 3'-GL), 4'-position (4'-galactosyllactose, 4'-GL), or the 6'-position (6'-galactosyllactose, 6'-GL). These GLs are of particular interest as they are present in both GOS mixtures and human milk at early stages of lactation. However, research on the potential health benefits of these individual GLs has been limited. Gram quantities are needed to assess their health benefits but these GLs are not readily available at this scale. In this study, we report the gram-scale chemical synthesis of 3'-GL, 4'-GL, and 6'-GL. All three galactosyllactoses were obtained on a gram scale in good purity from cheap and commercially available lactose. Furthermore, in vitro incubation of GLs with infant faecal microbiota demonstrates that the GLs were able to increase the abundance of Bifidobacterium and stimulate short chain fatty acid production.


Subject(s)
Gastrointestinal Microbiome , Lactose , Infant , Female , Humans , Lactose/pharmacology , Lactose/chemistry , Oligosaccharides/chemistry , Trisaccharides/pharmacology , Milk, Human/chemistry
19.
Food Res Int ; 177: 113872, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38225141

ABSTRACT

Lactose crystallization during storage deteriorates reconstitution performance of milk powders, but the relationship between lactose crystallization and reconstitution is inexplicit. The objective of this study is to characterize crystalline lactose in the context of formulation and elucidate the complex relationship between lactose crystallization and powder functionality. Lactose in Skim Milk Powder (SMP), Whole Milk Powder (WMP) and Fat-Filled Milk Powder (FFMP) stored under 23 %, 53 % and 75 % Relative Humidity (RH) at 25  â„ƒ for four months was compared. Lactose, surface chemistry and microstructure of FFMP stored at 25 â„ƒ and 40 â„ƒ at 23 % to 75 % RH for four months were also analyzed and interpreted. At the same RH, FFMP crystallized in the same pattern as WMP. At 53 % RH, FFMP and WMP differentiated from SMP in terms of lactose morphology as well as the ratio between anhydrous α-lactose and anhydrous ß-lactose. Lactose remained amorphous at 23 % RH, crystallized predominantly to α/ß-lactose (1:4) at 40 to 58 % RH and to α-lactose monohydrate at 75 % RH. The crystallinity index was similar for all powders containing crystalline lactose. The estimated crystallite size increased from approx. 0.1 to 20 µm with increasing RH and temperature. When amorphous lactose crystallized into crystals below approx. 0.1 µm at 25 °C and 43 % RH, the microstructure and surface lipid were comparable to that of the reference powder. This powder reconstituted into a stable suspension system comparable to that of reference (well performing) powders. These results demonstrate that crystallite size is the key property linking lactose crystallization and reconstitution. Our finding thus indicates limiting crystallite size is important for maintaining desired product quality.


Subject(s)
Lactose , Milk , Animals , Crystallization/methods , Milk/chemistry , Lactose/chemistry , Powders/chemistry , X-Ray Diffraction
20.
J Chromatogr A ; 1714: 464526, 2024 Jan 11.
Article in English | MEDLINE | ID: mdl-38071876

ABSTRACT

Over the last years, inverse gas chromatography (IGC) proved to be a versatile and sensitive analytical technique for physicochemical properties. However, the comparability of results obtained by different users and devices remains a topic for debate. This is the first time, an interlaboratory study using different types of IGC instruments is reported. Eight organizations with different IGC devices defined a common lab measurement protocol to analyse two standard materials, silica and lactose. All data was collected in a standard result form and has been treated identically with the objective to identify experimentally observed differences and not potentially different data treatments. The calculated values of the dispersive surface energy vary quite significantly (silica: 22 mJ/m2 - 34 mJ/m2, lactose 37 mJ/m2 - 51 mJ/m2) and so do the ISP values and retention volumes for both materials. This points towards significant and seemingly undiscovered differences in the operation of the instruments and the obtained underlying primary data, even under the premise of standard conditions. Variations are independent of the instrument type and uncertainties in flow rates or the injected quantities of probe molecules may be potential factors for the differences. This interlaboratory study demonstrates that the IGC is a very sensitive analytical tool, which detects minor changes, but it also shows that for a proper comparison, the measurement conditions have to be checked with great care. A publicly available standard protocol and material, for which this study can be seen as a starting point, is still needed to judge on the measurements and the resulting parameters more objectively.


Subject(s)
Lactose , Silicon Dioxide , Surface Properties , Lactose/chemistry , Reproducibility of Results , Chromatography, Gas/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...